MXBBB: Drug Recall
Recall #D-0166-2025 · 11/14/2024
Class II: Risk
Recall Details
- Recall Number
- D-0166-2025
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- MXBBB
- Status
- Ongoing
- Date Initiated
- 11/14/2024
- Location
- El Paso, TX, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 321 bottles
Reason for Recall
cGMP Deviations: the firm initiated a recall after notification from the distributor that product may be tainted with undeclared diclofenac and omeprazole, however there is no analytical data confirming that product distributed by the firm is tainted.
Product Description
UMARY ACID HYALURONIC, 850 MG CAPLETS, 30-count bottle, UPC7502265120323
Distribution Pattern
Product was sold via Amazon Marketplace.
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.